Dr. Michael J Wagner, MD
Claim this profileFred Hutchinson Cancer Research Center
Studies Liposarcoma
Studies Sarcoma
13 reported clinical trials
19 drugs studied
Area of expertise
1Liposarcoma
Stage IV
HLA-A positive
MAGE-A4 positive
2Sarcoma
SMARCB1 positive
SS18-SSX positive
HLA-A positive
Affiliated Hospitals
Clinical Trials Michael J Wagner, MD is currently running
Intratumoral Microdosing
for Cancer
This trial uses a device to inject small amounts of cancer drugs directly into tumors of patients undergoing surgery. The device marks where each drug is injected, allowing researchers to see how different parts of the tumor respond. This helps test cancer drugs early without causing widespread side effects. The device has been shown to induce strong, easily tracked, drug-specific responses in tumors while avoiding toxicity, setting the stage for its application in clinical trials.
Recruiting1 award Phase < 17 criteria
INBRX-109
for Chondrosarcoma
This trial tests INBRX-109, a specially designed protein, in patients with a hard-to-treat type of bone cancer. The treatment helps the immune system target and kill cancer cells by attaching to a specific marker on these cells.
Recruiting0 awards Phase 26 criteria
More about Michael J Wagner, MD
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Michael J Wagner, MD has experience with
- Pembrolizumab
- Nivolumab
- Paclitaxel
- FHD-609
- CIVO Intratumoral Microdosing
- Ipilimumab
Breakdown of trials Michael J Wagner, MD has run
Synovial Sarcoma
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael J Wagner, MD specialize in?
Michael J Wagner, MD focuses on Liposarcoma and Sarcoma. In particular, much of their work with Liposarcoma has involved Stage IV patients, or patients who are HLA-A positive.
Is Michael J Wagner, MD currently recruiting for clinical trials?
Yes, Michael J Wagner, MD is currently recruiting for 6 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Michael J Wagner, MD has studied deeply?
Yes, Michael J Wagner, MD has studied treatments such as Pembrolizumab, Nivolumab, Paclitaxel.
What is the best way to schedule an appointment with Michael J Wagner, MD?
Apply for one of the trials that Michael J Wagner, MD is conducting.
What is the office address of Michael J Wagner, MD?
The office of Michael J Wagner, MD is located at: Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutchinson Cancer Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.